According to GlobalData’s medical device pipeline database, six Breast Tomosynthesis devices are in various stages of development globally. GlobalData’s report Breast Tomosynthesis provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.

Smarter leaders trust GlobalData

Of these devices, five are in active development, while the remaining one is in an inactive stage of development. There are four products in the early stages of development, and the remaining one is in the late stages of development.

Diagnostic imaging devices are used for the visualization of structural and functional patterns of organs or tissues. Computed Tomography (CT) Systems, Mammography Equipment, MRI Systems, Nuclear Imaging Equipment, Ultrasound Systems, X-ray Systems, Bone Densitometers, Angio Suites, Contrast Media Injectors, Accessories, Contrast Agents, Radiopharmaceuticals and C-arms are covered under this market. Breast tomosynthesis is a system in which the imaging machines moves around the breast in an arc and taking multiple X-rays that is converted by the computer into 3D images Breast tomosynthesis is also called 3D mammography uses low-dose x-rays to create three-dimensional images of the breast. Tomosynthesis is often used in combination with traditional 2D mammography to improve the detection of breast cancer, especially in women with dense breasts.

Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.

Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed Breast Tomosynthesis pipeline devices are all expected to be approved within the next ten years.

Currently, private organizations, public entities and institutions are working on the development of Breast Tomosynthesis devices. Overall, most of these Breast Tomosynthesis pipeline devices are being developed by private entities.

Key players involved in the active development of Breast Tomosynthesis include Fischer Imaging, Florida International University, Philips Healthcare, Real Time Tomography, University of Chicago and University of Michigan.

For a complete picture of the developmental pipeline for Breast Tomosynthesis devices, buy the report here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. The Pipeline Products database is a is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.